메뉴 건너뛰기




Volumn 18, Issue 5, 2012, Pages 472-482

Therapeutic approach of hepatic sarcoidosis

Author keywords

hepatic; liver; nonalcoholic steatohepatitis; sarcoidosis; treatment

Indexed keywords

ADALIMUMAB; ANTIOXIDANT; AZATHIOPRINE; CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTOKINE; GLUTATHIONE; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; METHYLPREDNISOLONE; PENTOXIFYLLINE; PREDNISONE; REACTIVE OXYGEN METABOLITE; THALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; URSODEOXYCHOLIC ACID;

EID: 84864871230     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e3283541626     Document Type: Review
Times cited : (44)

References (87)
  • 1
    • 0033172779 scopus 로고    scopus 로고
    • Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999
    • Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999; 160:736-755.
    • (1999) Am J Respir Crit Care Med , vol.160 , pp. 736-755
  • 3
    • 0030900530 scopus 로고    scopus 로고
    • Outcome in sarcoidosis: The relationship of relapse to corticosteroid therapy
    • Gottlieb JE, Israel HL, Steiner RM, et al. Outcome in sarcoidosis. The relationship of relapse to corticosteroid therapy. Chest 1997; 111:623-631. (Pubitemid 27132936)
    • (1997) Chest , vol.111 , Issue.3 , pp. 623-631
    • Gottlieb, J.E.1    Israel, H.L.2    Steiner, R.M.3    Triolo, J.4    Patrick, H.5
  • 4
    • 77955043019 scopus 로고    scopus 로고
    • The etiologic role of infectious antigens in sarcoidosis pathogenesis
    • Oswald-Richter KA, Drake WP. The etiologic role of infectious antigens in sarcoidosis pathogenesis. Semin Respir Crit Care Med 2010; 31:375-379.
    • (2010) Semin Respir Crit Care Med , vol.31 , pp. 375-379
    • Oswald-Richter, K.A.1    Drake, W.P.2
  • 6
    • 33745264450 scopus 로고    scopus 로고
    • Natural history of hepatic sarcoidosis and its response to treatment
    • Kennedy PT, Zakaria N, Modawi SB, et al. Natural history of hepatic sarcoidosis and its response to treatment. Eur J Gastroenterol Hepatol 2006; 18:721-726.
    • (2006) Eur J Gastroenterol Hepatol , vol.18 , pp. 721-726
    • Kennedy, P.T.1    Zakaria, N.2    Modawi, S.B.3
  • 7
    • 58149384455 scopus 로고    scopus 로고
    • Gastrointestinal and hepatic manifestations of sarcoidosis
    • quiz 3193
    • Ebert EC, Kierson M, Hagspiel KD. Gastrointestinal and hepatic manifestations of sarcoidosis. Am J Gastroenterol 2008; 103:3184-3192; quiz 3193.
    • (2008) Am J Gastroenterol , vol.103 , pp. 3184-3192
    • Ebert, E.C.1    Kierson, M.2    Hagspiel, K.D.3
  • 9
    • 44649145277 scopus 로고    scopus 로고
    • Hepatic, ocular, and cutaneous sarcoidosis
    • DOI 10.1016/j.ccm.2008.03.008, PII S027252310800035X
    • Rose AS, Tielker MA, Knox KS. Hepatic, ocular, and cutaneous sarcoidosis. Clin Chest Med 2008; 29:509-524; ix. (Pubitemid 351778208)
    • (2008) Clinics in Chest Medicine , vol.29 , Issue.3 , pp. 509-524
    • Rose, A.S.1    Tielker, M.A.2    Knox, K.S.3
  • 10
    • 0036914146 scopus 로고    scopus 로고
    • Hepatic, splenic, and gastrointestinal involvement with sarcoidosis
    • DOI 10.1055/s-2002-36517
    • Judson MA. Hepatic, splenic, and gastrointestinal involvement with sarcoidosis. Semin Respir Crit Care Med 2002; 23:529-541. (Pubitemid 36026366)
    • (2002) Seminars in Respiratory and Critical Care Medicine , vol.23 , Issue.6 , pp. 529-541
    • Judson, M.A.1
  • 13
    • 0034424752 scopus 로고    scopus 로고
    • Hepatic granulomas and hepatic sarcoidosis
    • ix-x
    • Valla DC, Benhamou JP. Hepatic granulomas and hepatic sarcoidosis. Clin Liver Dis 2000; 4:269-285; ix-x.
    • (2000) Clin Liver Dis , vol.4 , pp. 269-285
    • Valla, D.C.1    Benhamou, J.P.2
  • 14
    • 84859910080 scopus 로고    scopus 로고
    • Disseminated sarcoidosis presenting as granulomatous gastritis: A clinical review of the gastrointestinal and hepatic manifestations of sarcoidosis
    • Epub ahead of print
    • Dulai PS, Rothstein RI. Disseminated sarcoidosis presenting as granulomatous gastritis: a clinical review of the gastrointestinal and hepatic manifestations of sarcoidosis. J Clin Gastroenterol 2012. [Epub ahead of print]
    • (2012) J Clin Gastroenterol
    • Dulai, P.S.1    Rothstein, R.I.2
  • 16
    • 0029065210 scopus 로고
    • Nodular sarcoidosis of the liver and spleen: Analysis of 32 cases
    • Warshauer DM, Molina PL, Hamman SM, et al. Nodular sarcoidosis of the liver and spleen: analysis of 32 cases. Radiology 1995; 195:757-762.
    • (1995) Radiology , vol.195 , pp. 757-762
    • Warshauer, D.M.1    Molina, P.L.2    Hamman, S.M.3
  • 19
    • 0033645047 scopus 로고    scopus 로고
    • Hepatic sarcoidosis: Clinicopathologic features in thirty-seven patients
    • Bilir M, Mert A, Ozaras R, et al. Hepatic sarcoidosis: clinicopathologic features in thirty-seven patients. J Clin Gastroenterol 2000; 31:337-338.
    • (2000) J Clin Gastroenterol , vol.31 , pp. 337-338
    • Bilir, M.1    Mert, A.2    Ozaras, R.3
  • 21
    • 0030896101 scopus 로고    scopus 로고
    • Course of asymptomatic liver involvement in sarcoidosis: Role of therapy in selected cases
    • Vatti R, Sharma OP. Course of asymptomatic liver involvement in sarcoidosis: role of therapy in selected cases. Sarcoidosis Vasc Diffuse Lung Dis 1997; 14:73-76. (Pubitemid 27170558)
    • (1997) Sarcoidosis Vasculitis and Diffuse Lung Disease , vol.14 , Issue.1 , pp. 73-76
    • Vatti, R.1    Sharma, O.P.2
  • 22
    • 0037244516 scopus 로고    scopus 로고
    • Treatment of sarcoidosis - From a basic science point of view
    • DOI 10.1046/j.1365-2796.2003.01075.x
    • Moller DR. Treatment of sarcoidosis: from a basic science point of view. J Intern Med 2003; 253:31-40. (Pubitemid 36120995)
    • (2003) Journal of Internal Medicine , vol.253 , Issue.1 , pp. 31-40
    • Moller, D.R.1
  • 24
    • 0014844763 scopus 로고
    • Sarcoidosis and chronic hepatic disease: A clinical and pathologic study of 20 patients
    • Maddrey WC, Johns CJ, Boitnott JK, Iber FL. Sarcoidosis and chronic hepatic disease: a clinical and pathologic study of 20 patients. Medicine 1970; 49:375-395.
    • (1970) Medicine , vol.49 , pp. 375-395
    • Maddrey, W.C.1    Johns, C.J.2    Boitnott, J.K.3    Iber, F.L.4
  • 25
    • 59349092007 scopus 로고    scopus 로고
    • Antioxidant status associated with inflammation in sarcoidosis: A potential role for antioxidants
    • Boots AW, Drent M, Swennen EL, et al. Antioxidant status associated with inflammation in sarcoidosis: a potential role for antioxidants. Respir Med 2009; 103:364-372.
    • (2009) Respir Med , vol.103 , pp. 364-372
    • Boots, A.W.1    Drent, M.2    Swennen, E.L.3
  • 26
    • 79952622786 scopus 로고    scopus 로고
    • Butyrophilin-like 2 in pulmonary sarcoidosis: A factor for susceptibility and progression?
    • Wijnen PA, Voorter CE, Nelemans PJ, et al. Butyrophilin-like 2 in pulmonary sarcoidosis: a factor for susceptibility and progression? Hum Immunol 2011; 72:342-347.
    • (2011) Hum Immunol , vol.72 , pp. 342-347
    • Wijnen, P.A.1    Voorter, C.E.2    Nelemans, P.J.3
  • 27
    • 76249084043 scopus 로고    scopus 로고
    • The role of tumor necrosis factor alpha G-308A polymorphisms in the course of pulmonary sarcoidosis
    • Wijnen PA, Nelemans PJ, Verschakelen JA, et al. The role of tumor necrosis factor alpha G-308A polymorphisms in the course of pulmonary sarcoidosis. Tissue antigens 2010; 75:262-268.
    • (2010) Tissue Antigens , vol.75 , pp. 262-268
    • Wijnen, P.A.1    Nelemans, P.J.2    Verschakelen, J.A.3
  • 30
    • 34548725164 scopus 로고    scopus 로고
    • Potential etiologic agents in sarcoidosis
    • DOI 10.1513/pats.200608-155MS
    • Moller DR. Potential etiologic agents in sarcoidosis. Proc Am Thorac Soc 2007; 4:465-468. (Pubitemid 47435374)
    • (2007) Proceedings of the American Thoracic Society , vol.4 , Issue.5 , pp. 465-468
    • Moller, D.R.1
  • 32
    • 79960691818 scopus 로고    scopus 로고
    • Quercetin reduces markers of oxidative stress and inflammation in sarcoidosis
    • Boots AW, Drent M, de Boer VC, et al. Quercetin reduces markers of oxidative stress and inflammation in sarcoidosis. Clin Nutr 2011; 30:506-512.
    • (2011) Clin Nutr , vol.30 , pp. 506-512
    • Boots, A.W.1    Drent, M.2    De Boer, V.C.3
  • 33
    • 0036710706 scopus 로고    scopus 로고
    • Oxidative stress, transcription factors and chromatin remodelling in lung inflammation
    • DOI 10.1016/S0006-2952(02)01153-X, PII S000629520201153X
    • Rahman I. Oxidative stress, transcription factors and chromatin remodelling in lung inflammation. Biochem Pharmacol 2002; 64:935-942. (Pubitemid 35232267)
    • (2002) Biochemical Pharmacology , vol.64 , Issue.5-6 , pp. 935-942
    • Rahman, I.1
  • 34
    • 0035840849 scopus 로고    scopus 로고
    • Oxidative stress and lung inflammation in airways disease
    • DOI 10.1016/S0014-2999(01)01320-6, PII S0014299901013206
    • MacNee W. Oxidative stress and lung inflammation in airways disease. Eur J Pharmacol 2001; 429:195-207. (Pubitemid 33043996)
    • (2001) European Journal of Pharmacology , vol.429 , Issue.1-3 , pp. 195-207
    • MacNee, W.1
  • 36
    • 33847787156 scopus 로고    scopus 로고
    • Steroid-resistant sarcoidosis: Is antagonism of TNF-alpha the answer?
    • DOI 10.1042/CS20060094
    • Denys BG, Bogaerts Y, Coenegrachts KL, De Vriese AS. Steroid-resistant sarcoidosis: is antagonism of TNF-alpha the answer? Clin Sci (Lond) 2007; 112:281-289. (Pubitemid 46392115)
    • (2007) Clinical Science , vol.112 , Issue.5-6 , pp. 281-289
    • Denys, B.G.1    Bogaerts, Y.2    Coenegrachts, K.L.3    De Vriese, A.S.4
  • 39
    • 0030752668 scopus 로고    scopus 로고
    • The role of granulomatous phlebitis and thrombosis in the pathogenesis of cirrhosis and portal hypertension in sarcoidosis
    • Moreno-Merlo F, Wanless IR, Shimamatsu K, et al. The role of granulomatous phlebitis and thrombosis in the pathogenesis of cirrhosis and portal hypertension in sarcoidosis. Hepatology 1997; 26:554-560. (Pubitemid 27392343)
    • (1997) Hepatology , vol.26 , Issue.3 , pp. 554-560
    • Moreno-Merlo, F.1    Wanless, I.R.2    Shimamatsu, K.3    Sherman, M.4    Greig, P.5    Chiasson, D.6
  • 40
    • 79954764140 scopus 로고    scopus 로고
    • A randomized controlled trial of highdose ursodesoxycholic acid for nonalcoholic steatohepatitis
    • Ratziu V, de Ledinghen V, Oberti F, et al. A randomized controlled trial of highdose ursodesoxycholic acid for nonalcoholic steatohepatitis. J Hepatol 2011; 54:1011-1019.
    • (2011) J Hepatol , vol.54 , pp. 1011-1019
    • Ratziu, V.1    De Ledinghen, V.2    Oberti, F.3
  • 41
    • 14544294003 scopus 로고    scopus 로고
    • Effect of ursodeoxycholic acid on granulomatous liver disease due to sarcoidosis
    • DOI 10.1007/s10620-005-1300-2
    • Alenezi B, Lamoureux E, Alpert L, Szilagyi A. Effect of ursodeoxycholic acid on granulomatous liver disease due to sarcoidosis. Dig Dis Sci 2005; 50:196-200. (Pubitemid 40379162)
    • (2005) Digestive Diseases and Sciences , vol.50 , Issue.1 , pp. 196-200
    • Alenezi, B.1    Lamoureux, E.2    Alpert, L.3    Szilagyi, A.4
  • 43
    • 0021042333 scopus 로고
    • Sarcoidosis presenting as biliary cirrhosis: Treatment with chlorambucil
    • Hughes GS Jr, Kataria YP, O'Brien TF Jr. Sarcoidosis presenting as biliary cirrhosis: treatment with chlorambucil. South Med J 1983; 76:1440-1442. (Pubitemid 14203663)
    • (1983) Southern Medical Journal , vol.76 , Issue.11 , pp. 1440-1442
    • Hughes Jr., G.S.1    Kataria, Y.P.2    O'Brien Jr., T.F.3
  • 44
    • 0033831246 scopus 로고    scopus 로고
    • Ursodeoxycholic acid treatment in abdominal sarcoidosis
    • Baratta L, Cascino A, Delfino M, et al. Ursodeoxycholic acid treatment in abdominal sarcoidosis. Dig Dis Sci 2000; 45:1559-1562.
    • (2000) Dig Dis Sci , vol.45 , pp. 1559-1562
    • Baratta, L.1    Cascino, A.2    Delfino, M.3
  • 45
    • 57049125016 scopus 로고    scopus 로고
    • Hepatobiliary and pancreatic: Cirrhosis secondary to hepatic sarcoidosis
    • Malhotra A, Naniwadekar A, Sood G. Hepatobiliary and pancreatic: cirrhosis secondary to hepatic sarcoidosis. J Gastroenterol Hepatol 2008; 23:1942.
    • (2008) J Gastroenterol Hepatol , vol.23 , pp. 1942
    • Malhotra, A.1    Naniwadekar, A.2    Sood, G.3
  • 47
    • 80355138040 scopus 로고    scopus 로고
    • Effectiveness and safety of leflunomide for pulmonary and extrapulmonary sarcoidosis
    • Sahoo DH, Bandyopadhyay D, Xu M, et al. Effectiveness and safety of leflunomide for pulmonary and extrapulmonary sarcoidosis. Eur Respir J 2011; 38:1145-1150.
    • (2011) Eur Respir J , vol.38 , pp. 1145-1150
    • Sahoo, D.H.1    Bandyopadhyay, D.2    Xu, M.3
  • 51
    • 0346850596 scopus 로고    scopus 로고
    • Successful Tumor Necrosis Factor alpha Blockade Treatment in Therapy-Resistant Sarcoidosis
    • DOI 10.1002/art.11357
    • Ulbricht KU, Stoll M, Bierwirth J, et al. Successful tumor necrosis factor alpha blockade treatment in therapy-resistant sarcoidosis. Arthritis Rheum 2003; 48:3542-3543. (Pubitemid 37531922)
    • (2003) Arthritis and Rheumatism , vol.48 , Issue.12 , pp. 3542-3543
    • Ulbricht, K.U.1    Stoll, M.2    Bierwirth, J.3    Witte, T.4    Schmidt, R.E.5
  • 52
    • 15844414943 scopus 로고    scopus 로고
    • Treatment of sarcoidosis with infliximab
    • DOI 10.1378/chest.127.3.1064
    • Doty JD, Mazur JE, Judson MA. Treatment of sarcoidosis with infliximab. Chest 2005; 127:1064-1071. (Pubitemid 40775543)
    • (2005) Chest , vol.127 , Issue.3 , pp. 1064-1071
    • Doty, J.D.1    Mazur, J.E.2    Judson, M.A.3
  • 53
    • 33749488305 scopus 로고    scopus 로고
    • Effectiveness of infliximab in treating selected patients with sarcoidosis
    • DOI 10.1016/j.rmed.2006.02.017, PII S0954611106000679
    • Saleh S, Ghodsian S, Yakimova V, et al. Effectiveness of infliximab in treating selected patients with sarcoidosis. Respir Med 2006; 100:2053-2059. (Pubitemid 44514944)
    • (2006) Respiratory Medicine , vol.100 , Issue.11 , pp. 2053-2059
    • Saleh, S.1    Ghodsian, S.2    Yakimova, V.3    Henderson, J.4    Sharma, O.P.5
  • 54
    • 49649098822 scopus 로고    scopus 로고
    • Efficacy of infliximab in extrapulmonary sarcoidosis: Results from a randomised trial
    • Judson MA, Baughman RP, Costabel U, et al. Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial. Eur Respir J 2008; 31:1189-1196.
    • (2008) Eur Respir J , vol.31 , pp. 1189-1196
    • Judson, M.A.1    Baughman, R.P.2    Costabel, U.3
  • 56
    • 4344679827 scopus 로고    scopus 로고
    • Pulmonary sarcoidosis
    • DOI 10.1016/j.ccm.2004.04.006, PII S0272523104000504
    • Baughman RP. Pulmonary sarcoidosis. Clin Chest Med 2004; 25:521-530; vi. (Pubitemid 39149799)
    • (2004) Clinics in Chest Medicine , vol.25 , Issue.3 , pp. 521-530
    • Baughman, R.P.1
  • 57
    • 0023805363 scopus 로고
    • Sarcoidosis. Usual and unusual manifestations
    • Baughman RP. Sarcoidosis. Usual and unusual manifestations. Chest 1988; 94:165-170.
    • (1988) Chest , vol.94 , pp. 165-170
    • Baughman, R.P.1
  • 58
    • 0017859628 scopus 로고
    • Granulomatous Biliary Tract Obstruction due to Sarcoidosis. Report of a case and review of the literature
    • Bloom R, Sybert A, Mascatello VJ. Granulomatous biliary tract obstruction due to sarcoidosis. Report of a case and review of the literature. Am J Respir Dis 1978; 117:783-787. (Pubitemid 8334985)
    • (1978) American Review of Respiratory Disease , vol.117 , Issue.4 , pp. 783-787
    • Bloom, R.1    Sybert, A.2    Mascatello, V.J.3
  • 61
    • 66749086530 scopus 로고    scopus 로고
    • TPMT testing before azathioprine therapy?
    • Wan Y. TPMT testing before azathioprine therapy? Drug Ther Bull 2009; 47:9-12.
    • (2009) Drug Ther Bull , vol.47 , pp. 9-12
    • Wan, Y.1
  • 62
    • 0037242825 scopus 로고    scopus 로고
    • Difficult treatment issues in sarcoidosis
    • DOI 10.1046/j.1365-2796.2003.01076.x
    • Baughman RP, Lynch JP. Difficult treatment issues in sarcoidosis. J Intern Med 2003; 253:41-45. (Pubitemid 36120996)
    • (2003) Journal of Internal Medicine , vol.253 , Issue.1 , pp. 41-45
    • Baughman, R.P.1    Lynch, J.P.2
  • 63
    • 77949874647 scopus 로고    scopus 로고
    • Thiopurine S-methyltransferase [corrected] testing in idiopathic pulmonary fibrosis: A pharmacogenetic cost-effectiveness analysis
    • Hagaman JT, Kinder BW, Eckman MH. Thiopurine S-methyltransferase [corrected] testing in idiopathic pulmonary fibrosis: a pharmacogenetic cost-effectiveness analysis. Lung 2010; 188:125-132.
    • (2010) Lung , vol.188 , pp. 125-132
    • Hagaman, J.T.1    Kinder, B.W.2    Eckman, M.H.3
  • 64
    • 0024339093 scopus 로고
    • HBcAg expressed on the surface of circulating Dane particles in patients with hepatitis B virus infection without evidence of anti-HBc formation
    • Moller B, Hopf U, Stemerowicz R, et al. HBcAg expressed on the surface of circulating Dane particles in patients with hepatitis B virus infection without evidence of anti-HBc formation. Hepatology 1989; 10:179-185. (Pubitemid 19190208)
    • (1989) Hepatology , vol.10 , Issue.2 , pp. 179-185
    • Moller, B.1    Hopf, U.2    Stemerowicz, R.3    Henze, G.4    Gelderblom, H.5
  • 65
    • 0026315404 scopus 로고
    • Methotrexate and histologic hepatic abnormalities: A meta-analysis
    • Whiting-O'Keefe QE, Fye KH, Sack KD. Methotrexate and histologic hepatic abnormalities: a meta-analysis. Am J Med 1991; 90:711-716.
    • (1991) Am J Med , vol.90 , pp. 711-716
    • Whiting-O'keefe, Q.E.1    Fye, K.H.2    Sack, K.D.3
  • 66
    • 81155133749 scopus 로고    scopus 로고
    • Inflammatory activity assessment by F18 FDG-PET/CT in persistent symptomatic sarcoidosis
    • Mostard RL, Voo S, van Kroonenburgh MJ, et al. Inflammatory activity assessment by F18 FDG-PET/CT in persistent symptomatic sarcoidosis. Respir Med 2011; 105:1917-1924.
    • (2011) Respir Med , vol.105 , pp. 1917-1924
    • Mostard, R.L.1    Voo, S.2    Van Kroonenburgh, M.J.3
  • 67
  • 68
    • 84864881323 scopus 로고    scopus 로고
    • Effect of the TNF-alpha inhibitor adalimumab in patients with recalcitrant sarcoidosis: A prospective observational study using FDG-PET
    • Epub ahead of print
    • Milman N, Graudal N, Loft A, et al. Effect of the TNF-alpha inhibitor adalimumab in patients with recalcitrant sarcoidosis: a prospective observational study using FDG-PET. Clin Respir J 2011. [Epub ahead of print].
    • (2011) Clin Respir J
    • Milman, N.1    Graudal, N.2    Loft, A.3
  • 69
    • 81455131960 scopus 로고    scopus 로고
    • Emerging role of whole-body 18F-fluorodeoxyglucose positron emission tomography as a marker of disease activity in patients with sarcoidosis: A systematic review
    • Treglia G, Taralli S, Giordano A. Emerging role of whole-body 18F-fluorodeoxyglucose positron emission tomography as a marker of disease activity in patients with sarcoidosis: a systematic review. Sarcoidosis Vasc Diffuse Lung Dis 2011; 28:87-94.
    • (2011) Sarcoidosis Vasc Diffuse Lung Dis , vol.28 , pp. 87-94
    • Treglia, G.1    Taralli, S.2    Giordano, A.3
  • 71
    • 0242636885 scopus 로고    scopus 로고
    • Treatment of Corticosteroid-Resistant Neurosarcoidosis with a Short-Course Cyclophosphamide Regimen
    • DOI 10.1378/chest.124.5.2023
    • Doty JD, Mazur JE, Judson MA. Treatment of corticosteroid-resistant neurosarcoidosis with a short-course cyclophosphamide regimen. Chest 2003; 124:2023-2026. (Pubitemid 37433608)
    • (2003) Chest , vol.124 , Issue.5 , pp. 2023-2026
    • Doty, J.D.1    Mazur, J.E.2    Judson, M.A.3
  • 72
    • 5344258973 scopus 로고    scopus 로고
    • Adverse effects of thalidomide administration in patients with neoplastic diseases
    • DOI 10.1016/j.amjmed.2004.03.040, PII S0002934304004309
    • Dimopoulos MA, Eleutherakis-Papaiakovou V. Adverse effects of thalidomide administration in patients with neoplastic diseases. Am J Med 2004; 117:508-515. (Pubitemid 39349589)
    • (2004) American Journal of Medicine , vol.117 , Issue.7 , pp. 508-515
    • Dimopoulos, M.A.1    Eleutherakis-Papaiakovou, V.2
  • 73
    • 77649240656 scopus 로고    scopus 로고
    • Steroid-sparing effects of pentoxifylline in pulmonary sarcoidosis
    • Park MK, Fontana, JR, Babaali H, et al. Steroid-sparing effects of pentoxifylline in pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2009; 26:121-131.
    • (2009) Sarcoidosis Vasc Diffuse Lung Dis , vol.26 , pp. 121-131
    • Park, M.K.1    Fontana, J.R.2    Babaali, H.3
  • 74
    • 80055028155 scopus 로고    scopus 로고
    • Pentoxifylline improves nonalcoholic steatohepatitis: A randomized placebo-controlled trial
    • Zein CO, Yerian LM, Gogate P, et al. Pentoxifylline improves nonalcoholic steatohepatitis: a randomized placebo-controlled trial. Hepatology 2011; 54:1610-1619.
    • (2011) Hepatology , vol.54 , pp. 1610-1619
    • Zein, C.O.1    Yerian, L.M.2    Gogate, P.3
  • 76
    • 62549134888 scopus 로고    scopus 로고
    • Inhibitors of tumor necrosis factor (TNF) in sarcoidosis: Who, what, and how to use them
    • Baughman RP, Lower EE, Drent M. Inhibitors of tumor necrosis factor (TNF) in sarcoidosis: who, what, and how to use them. Sarcoidosis Vasc Diffuse Lung Dis 2008; 25:76-89.
    • (2008) Sarcoidosis Vasc Diffuse Lung Dis , vol.25 , pp. 76-89
    • Baughman, R.P.1    Lower, E.E.2    Drent, M.3
  • 77
    • 0034039605 scopus 로고    scopus 로고
    • Chimeric anti-tumor necrosis factor-alpha monoclonal antibody treatment of patients with rheumatoid arthritis receiving methotrexate therapy
    • Kavanaugh A, St Clair EW, McCune WJ, et al. Chimeric antitumor necrosis factor-alpha monoclonal antibody treatment of patients with rheumatoid arthritis receiving methotrexate therapy. J Rheumatol 2000; 27:841-850. (Pubitemid 30389736)
    • (2000) Journal of Rheumatology , vol.27 , Issue.4 , pp. 841-850
    • Kavanaugh, A.1    St. Clair, E.W.2    McCune, W.J.3    Braakman, T.4    Lipsky, P.5
  • 79
    • 80051992028 scopus 로고    scopus 로고
    • Outcomes of orthotopic liver transplantation for hepatic sarcoidosis: An analysis of the United Network for Organ Sharing/Organ Procurement and Transplantation Network data files for a comparative study with cholestatic liver diseases
    • Vanatta JM, Modanlou KA, Dean AG, et al. Outcomes of orthotopic liver transplantation for hepatic sarcoidosis: an analysis of the United Network for Organ Sharing/Organ Procurement and Transplantation Network data files for a comparative study with cholestatic liver diseases. Liver Transpl 2011; 17:1027-1034.
    • (2011) Liver Transpl , vol.17 , pp. 1027-1034
    • Vanatta, J.M.1    Modanlou, K.A.2    Dean, A.G.3
  • 80
    • 22244490672 scopus 로고    scopus 로고
    • Patient and graft outcomes following liver transplantation for sarcoidosis
    • DOI 10.1111/j.1399-0012.2005.00372.x
    • Lipson EJ, Fiel MI, Florman SS, Korenblat KM. Patient and graft outcomes following liver transplantation for sarcoidosis. Clin Transplant 2005; 19:487-491. (Pubitemid 40990658)
    • (2005) Clinical Transplantation , vol.19 , Issue.4 , pp. 487-491
    • Lipson, E.J.1    Fiel, M.I.2    Florman, S.S.3    Korenblat, K.M.4
  • 82
    • 0033046922 scopus 로고    scopus 로고
    • Sarcoidosis with selective involvement of a second liver allograft: Report of a case and review of the literature
    • Hunt J, Gordon FD, Jenkins RL, et al. Sarcoidosis with selective involvement of a second liver allograft: report of a case and review of the literature. Mod Pathol 1999; 12:325-328. (Pubitemid 29133855)
    • (1999) Modern Pathology , vol.12 , Issue.3 , pp. 325-328
    • Hunt, J.1    Gordon, F.D.2    Jenkins, R.L.3    Lewis, W.D.4    Khettry, U.5
  • 83
    • 84858842467 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease: Multimodal treatment options for a pathogenetically multiple-hit disease
    • Polyzos SA, Kountouras J, Zavos C, Deretzi G. Nonalcoholic fatty liver disease: multimodal treatment options for a pathogenetically multiple-hit disease. J Clin Gastroenterol 2012; 46:272-284.
    • (2012) J Clin Gastroenterol , vol.46 , pp. 272-284
    • Polyzos, S.A.1    Kountouras, J.2    Zavos, C.3    Deretzi, G.4
  • 84
    • 72549089785 scopus 로고    scopus 로고
    • Targeting the TNF-alpha pathway in sarcoidosis
    • Antoniu SA. Targeting the TNF-alpha pathway in sarcoidosis. Expert Opin Ther Targets 2010; 14:21-29.
    • (2010) Expert Opin Ther Targets , vol.14 , pp. 21-29
    • Antoniu, S.A.1
  • 85
    • 77952529040 scopus 로고    scopus 로고
    • A position statement on NAFLD/NASH based on the EASL 2009 special conference
    • Ratziu V, Bellentani S, Cortez-Pinto H, et al. A position statement on NAFLD/NASH based on the EASL 2009 special conference. J Hepatol 2010; 53:372-384.
    • (2010) J Hepatol , vol.53 , pp. 372-384
    • Ratziu, V.1    Bellentani, S.2    Cortez-Pinto, H.3
  • 86
    • 80053951780 scopus 로고    scopus 로고
    • Antioxidants as therapeutic agents for liver disease
    • Singal AK, Jampana SC, Weinman SA. Antioxidants as therapeutic agents for liver disease. Liver Int 2011; 31:1432-1448.
    • (2011) Liver Int , vol.31 , pp. 1432-1448
    • Singal, A.K.1    Jampana, S.C.2    Weinman, S.A.3
  • 87
    • 84862517200 scopus 로고    scopus 로고
    • Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in nonalcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of randomised trials
    • Musso G, Cassader M, Rosina F, Gambino R. Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in nonalcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials. Diabetologia 2012; 55:885-904.
    • (2012) Diabetologia , vol.55 , pp. 885-904
    • Musso, G.1    Cassader, M.2    Rosina, F.3    Gambino, R.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.